ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Fda Grants Strides Pharma Approval For Amantadine Hydrochloride Softgel Capsules 100mg
News Feed
course image
  • 22 Feb 2022
  • Admin
  • News Article

FDA grants Strides Pharma approval for Amantadine Hydrochloride Softgel Capsules 100mg

The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc. Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Amantadine Hydrochloride Softgel Capsules USP, 100mg from the United States Food & Drug Administration (US FDA). The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc. Biological E receives DCGI approval for administration of Warburg Pincus to invest $ 210 million in medical devices firm Meril Kolkata: Pvt hosps stare at wastage of vax, some plan free shots After 2 years, regular international flights may resume from next month Pharma strides pharma Symmetrel Capsules Health news FDA Endo Pharmaceuticals Amantadine Hydrochloride Softgel Capsules According to IQVIA MAT December 2021 data, the US market for Amantadine Hydrochloride Capsules USP,100mg is approximately $11 million. The product will be manufactured at the company

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form